The Tamesis
Photo by Nwato
One analyst said further research and clinical trials would address unmet needs in the industry.
GlobalData says there is an unmet long-term treatment need for chronic hand eczema (CHE), creating a clear need for new therapies.
Although topical corticosteroids are widely used for their anti-inflammatory properties, their long-term use is limited by side effects such as skin thinning.
Meanwhile, treatments like emollients and moisturizers can provide moisture but don't address the underlying inflammation.
“Doctors may prescribe immunosuppressants such as calcineurin inhibitors, but long-term use may have negative consequences, including kidney dysfunction,” said GlobalData healthcare analyst Filippos Maniatis.
“To address unmet needs in CHE treatment, further research and clinical trials focused on safety and patient quality of life are critical,” Maniatis added.
Join the Asian Healthcare Magazine Community
Now that you're here…
….There are many ways you can work with us to promote your company and connect with your customers. Our team can help you plan and create print and digital advertising campaigns on this website and in the print magazine.
We can also organize real-life or digital events for you and source thought-leader speakers and industry leaders (who may be your potential partners) to attend your events. We also run a number of awards programs that give you the opportunity to be recognized for your achievements during the year, and you can join as a participant or sponsor.
Let us help you drive business development through good partnerships!
